Status:
NOT_YET_RECRUITING
A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations
Lead Sponsor:
Amina Aslam
Conditions:
COPD
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
This study will include patients with chronic obstructive pulmonary disease (COPD) who present with an acute exacerbation. Participants will be randomly assigned to receive either doxycycline or levof...
Detailed Description
This randomized controlled trial will evaluate the effectiveness of two antibiotics-doxycycline (a tetracycline) and levofloxacin (a fluoroquinolone)-in the treatment of acute exacerbations of chronic...
Eligibility Criteria
Inclusion
- diagnosed cases of COPD Exacerbation of COPD Able to provide Written consent No anti biotic taken with in past 4 weeks
Exclusion
- hypersensitivity to any drugs Pneumonia evidence on xray/ hrct chest Any other pulmonary condition e.g asthma Pregnancy/breast feeding Taking treatment for other active infections
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
188 Patients enrolled
Trial Details
Trial ID
NCT06915688
Start Date
April 15 2025
End Date
July 31 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General hospital
Lahore, Pakistan